Introduction:Osteoporosis is relatively a serious medical condition causing geriatric trauma, which leads to an increase in morbidity and mortality. Early fracture union is important for early mobilization and for good functional outcome. Recombinant parathyroid hormone has shown to accelerate the fracture union and improve the functional outcome. Therefore, in this study we have decided to evaluate the effectiveness of recombinant parathyroid hormone. Methods: Our study includes 24 osteoporotic intertrochanteric fracture patients who underwent surgical management at our institute. Post operatively Inj. Teriparatide 20mcg subcutaneously was started for 3 months. Radiological and functional outcome were evaluated at 4,8,12 and 24 weeks. Results: The average time of fracture union was 8-12 weeks using RUSH score and the patients had better functional outcome using Harris hip score and VAS score.
Conclusion:We have evaluated the effectiveness of recombinant parathyroid hormone given post operatively for 3 months for osteoporotic intertrochanteric fracture, which showed a significant shorter time for fracture union and a significant improvement in functional outcome.
INTRODUCTION:Osteoporotic intertrochanteric fracture is a relatively common and serious medical issue resulting in serious health problems and decrease health related quality of life. Faster timeto-union is important for early return to daily activities and reduction of complications. Hip fractures are a burden on the healthcare system. Complications after hip fractures contributes to high mortality and adverse outcomes 1 . The average mortality rate after fracture fixation has reduced grossly up to 13.3%. 2